piracetam has been researched along with Ovarian Neoplasms in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwiecińska, P | 3 |
Wróbel, A | 1 |
Taubøll, E | 3 |
Gregoraszczuk, EŁ | 1 |
Halbert, RK | 1 |
Mataam, K | 1 |
Ilboudo, JC | 1 |
Gazaigne, L | 1 |
Wafo, E | 1 |
Angenard, F | 1 |
Gregoraszczuk, EL | 2 |
5 other studies available for piracetam and Ovarian Neoplasms
Article | Year |
---|---|
Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Histone Deacetylase 2; Histone Deacetylase Inhibito | 2014 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Study.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Cyclophosphamide; Fatal Out | 2016 |
[Two cases of autoimmune encephalitis with antibodies to N-methyl-D-aspartate receptor in intensive care].
Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; Autoimmune Diseases of the Nervous System; Critical | 2012 |
Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Topics: Anticonvulsants; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female | 2012 |
Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Far-Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, | 2012 |